CJC/Ipamorelin
CJC-1295 / Ipamorelin · 20mg lyophilized blend
One-Time
No commitment
Monthly
Every 30 days
Save 20%Bi-Monthly
Every 60 days
Save 15%Quarterly
Every 90 days
Save 10%$54.99 USD
2-10x
Secretagogue Activity
Literature-reported receptor activity model
6+ Days
Sustained Release
Extended half-life GH secretion
1.5-3x
IGF-1 Increase
Plasma IGF-I elevation for 9-11 days
Synergistic
Dual Pathway
GHRH + GHRP combined mechanism
Data from peer-reviewed research literature. Research findings depend on protocol and model. For research purposes only.
Mechanism of Action
CJC-1295 — C₁₅₂H₂₅₂N₄₄O₄₂ · MW 3367.97 Da · a synthetic 30-amino acid GHRH analog with Drug Affinity Complex (DAC) conjugation enabling albumin binding and extended plasma half-life. Ipamorelin — C₃₈H₄₉N₉O₅ · MW 711.85 Da · CAS 170851-70-4 · a selective pentapeptide ghrelin receptor (GHS-R1a) agonist. This blend combines two distinct receptor-mediated pathways: CJC-1295 activates the GHRH receptor to promote sustained pulsatile GH secretion, while Ipamorelin selectively targets GHS-R1a without documented cross-reactivity at ACTH or cortisol-releasing pathways in preclinical models. Research applications include dual-pathway secretagogue mechanism studies, pulsatile GH release kinetics analysis, and neuroendocrine signaling pathway characterization.
Documented Research Observations
- check_circle Documented endocrine marker elevation observed in pituitary cell culture systems and animal model studies.
- check_circle Sustained GH secretion patterns documented over 6+ hour observation windows in laboratory models.
- check_circle IGF-1 elevation (1.5-3x) observed in animal model serum analysis with extended half-life kinetics.
Research Applications
GHRH receptor activation studies, ghrelin receptor signaling (GHS-R1a) research, pulsatile secretion pattern analysis, dual-pathway secretagogue mechanism validation, neuroendocrine pathway investigation, and growth-factor axis modeling in laboratory and animal model systems.
Frequently Paired Together
Researchers commonly pair this product with other currently stocked Serenity compounds.
Compound Characteristics
Research Specifications
This compound is supplied for in vitro research, laboratory experimentation, and animal model studies only. Not for human consumption, human or veterinary use, or pharmaceutical application.
Molecular Profile
Storage Requirements
Key References
Disclaimer: This product is intended for research purposes only and is not for human consumption. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. All compounds are sold strictly as research chemicals. By purchasing, you agree that these products will be used solely for in vitro research, laboratory experimentation, or other lawful non-clinical purposes.
WARNING: THIS PRODUCT IS INTENDED FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION.